Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Fund Type: SICAV
  • Objective: European Region
  • Asset Class: Equity
  • Geographic Focus: European Region

Aviva Investors Sicav - European Equity Income Fund

+ Add to Watchlist

PRIEVI1:LX

291.06 EUR 1.27 0.43%

As of 00:59:30 ET on 01/30/2015.

Snapshot for Aviva Investors Sicav - European Equity Income Fund (PRIEVI1)

Year To Date: +7.65% 3-Month: +7.74% 3-Year: +16.85% 52-Week Range: 248.55 - 295.50
1-Month: +7.65% 1-Year: +13.93% 5-Year: +9.73% Beta vs MSDUE15X: 0.87

Mutual Fund Chart for PRIEVI1

No chart data available.
  • PRIEVI1:LX 291.06
  • 1M
  • 1Y
Interactive PRIEVI1 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for PRIEVI1

Aviva Investors Sicav - European Equity Income Fund is a SICAV incorporated in Luxembourg.The Funds's objective is capital growth. The Fund invests primarily in a portfolio of Euro-denominated equity and equity-related securities of continental European companies that are quoted or traded on developed stock markets and which appear to offer significant value.

Inception Date: 01-20-2003 Telephone: 352-40-28-20-261
Managers: GRAHAM ELLIOTT-SHIRCORE
Web Site: www.avivainvestors.com

Fundamentals for PRIEVI1

NAV (on 2015-01-30) 291.06
Assets (M) (on 2015-01-30) 177.38
Fund Leveraged N
Minimum Investment 500,000.00
Minimum Subsequent Investment 2,000.00

Dividends for PRIEVI1

No dividends reported

Fees & Expenses for PRIEVI1

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.75
Redemption Fee 0.00
12b1 Fee -
Expense Ratio -

Top Fund Holdings for PRIEVI1

Filing Date: 11/28/2014
Name Position Value % of Total
Roche Holding AG 51,233 12,341,758 7.234%
Novartis AG 113,748 8,852,032 5.189%
Total SA 156,675 7,047,242 4.131%
Bayer AG 56,801 6,854,461 4.018%
Unilever NV 183,285 6,004,417 3.519%
Allianz SE 37,282 5,152,372 3.020%
Swisscom AG 10,210 4,987,496 2.923%
ABB Ltd 273,591 4,939,295 2.895%
Swedbank AB 225,571 4,754,586 2.787%
BASF SE 57,609 4,197,104 2.460%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil